Exelixis Announces November 6 Webcast of Presentation at the CIBC World Markets 18th Annual Healthcare Conference

Wednesday, October 31, 2007 General News J E 4
SOUTH SAN FRANCISCO, Calif., Oct. 30 Exelixis,Inc. (Nasdaq: EXEL) announced today that Michael Morrissey, Ph.D., thecompany's president of research and development, will present at the CIBCWorld Markets 18th Annual Healthcare Conference at 4:15 p.m. (ET) / 1:15 p.m.(PT) on Tuesday, November 6, 2007.

The presentation will be webcast and may be accessed in the Event Calendarpage under Investors on the Exelixis website at

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated tothe discovery and development of novel small molecule therapeutics for thetreatment of cancer and other serious diseases. The company is leveraging itsfully integrated drug discovery platform to fuel the growth of its developmentpipeline, which is primarily focused on cancer. Currently, Exelixis' broadproduct pipeline includes investigational compounds in phase 2 and phase 1clinical development for cancer and renal disease. Exelixis has establishedstrategic corporate alliances with major pharmaceutical and biotechnologycompanies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech,Wyeth Pharmaceuticals and Daiichi-Sankyo. For more information, please visitthe company's web site at

SOURCE Exelixis, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Vanda Pharmaceuticals' VSF-173 Excessive Sleepines...
A Patients Right to Know: 'Silver Fillings' are 50...